Connect With Us
Subscribe Now
Log In
Home
News
Education
Health
Tech
STEM
Advanced Manufacturing & Logistics
Life Sciences
Ag INnovation
INPower
Videos
Big Wigs
Submit Big Wigs
Events
Innovate Southwest Indiana â Evansville
Innovate West Central Indiana – Terre Haute
Innovate East Central – Muncie
Innovate Northeast Indiana – Fort Wayne
Newsletters
Podcasts
On-Air
TV & Radio Listings
Content Studio
Sponsored Content
Contact
About IIB
Meet the Team
Contact Us
Advertise
Gift Cards
Flagship Stations
Gerry’s Message
Speaking Engagement Request
Search
GO
Connect With Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
PROCEPT BioRobotics Corporation - Common Stock
(NQ:
PRCT
)
28.73
-0.20 (-0.67%)
Streaming Delayed Price
Updated: 10:26 AM EST, Feb 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PROCEPT BioRobotics Corporation - Common Stock
< Previous
1
2
3
4
5
6
Next >
4 Analysts Assess PROCEPT BioRobotics: What You Need To Know
↗
February 26, 2025
Via
Benzinga
PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results
February 25, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
Earnings Scheduled For February 25, 2025
↗
February 25, 2025
Via
Benzinga
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference
February 07, 2025
From
PROCEPT BioRobotics
Via
GlobeNewswire
How Is The Market Feeling About PROCEPT BioRobotics?
↗
January 24, 2025
Via
Benzinga
5 Analysts Assess PROCEPT BioRobotics: What You Need To Know
↗
December 02, 2024
Via
Benzinga
Looking Into PROCEPT BioRobotics's Recent Short Interest
↗
November 14, 2024
Via
Benzinga
The Analyst Landscape: 6 Takes On PROCEPT BioRobotics
↗
November 14, 2024
Via
Benzinga
Spruce Point Sees Trouble Ahead For Procept BioRobotics
↗
January 16, 2025
Spruce Point Capital warns of Procept BioRobotics' overstated market potential and growth claims, citing niche product limitations and valuation risks.
Via
Benzinga
Morgan Stanley Maintains Positive MedTech Outlook Despite Setbacks in 2024, Upgrades Intuitive Surgical And Stryker, Downgrades Nevro And Glaukos
↗
December 02, 2024
Morgan Stanley upgrades key MedTech stocks, highlighting strong demand and growth potential, while downgrading others amid company-specific challenges.
Via
Benzinga
This Autodesk Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
December 02, 2024
Via
Benzinga
PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024
November 26, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics's Earnings Outlook
↗
October 25, 2024
Via
Benzinga
What Analysts Are Saying About PROCEPT BioRobotics Stock
↗
October 08, 2024
Via
Benzinga
Navigating 6 Analyst Ratings For PROCEPT BioRobotics
↗
September 16, 2024
Via
Benzinga
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
↗
November 03, 2024
Top mid-cap stock performers: MDGL (+51.70%), PRCT (+34.20%), GSAT (+33.98%), WGS (+31.17%), NXT (+25.91%), VFC (+25.82%), OMCL (+23.22%).
Via
Benzinga
PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock
October 29, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Royal Caribbean Sails Onto The IBD 50: Build Your List Of Stocks To Watch With These Top IBD Screens
↗
October 28, 2024
Royal Caribbean earns its spot on the Big Cap 20 with a best-possible 99 Composite Rating, putting it in the top 1% of all stocks.
Via
Investor's Business Daily
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
October 28, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Unveiling 4 Analyst Insights On PROCEPT BioRobotics
↗
August 22, 2024
Via
Benzinga
Surgical Robotics Provider PROCEPT BioRobotics' Q3 Earnings Beats Street View, Analyst Optimistic About Upside Potential
↗
October 28, 2024
PROCEPT BioRobotics stock gains as Q3 earnings beat estimates with revenue up 66% YoY, driven by strong system sales and consumable revenue growth.
Via
Benzinga
Topics
Earnings
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
↗
October 28, 2024
Via
Benzinga
Procept Biorobotics, A Top 5% Stock, Makes A Bullish Move On Quarterly Beat And Raise
↗
October 28, 2024
The company sells systems that perform aquablation to treat enlarged prostates.
Via
Investor's Business Daily
PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
October 28, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024
October 09, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer
October 07, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Jim Cramer Says This Retailer Yields 3%: 'Which Is Quite Good'
↗
September 04, 2024
Jim Cramer discusses PROCEPT BioRobotics, Zoetis, Target and Consolidated Edison. "
Via
Benzinga
PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024
August 28, 2024
From
PROCEPT BioRobotics
Via
GlobeNewswire
Lucid, Grifols And Amer Sports Are Among Top 8 Mid Cap Stock Gainers Last Week (Aug 18-Aug 24): Are The Others In Your Portfolio?
↗
August 25, 2024
Via
Benzinga
Nasdaq Gains 0.5%; TJX Earnings Top Estimates
↗
August 21, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
